Transport of human growth hormone across Caco-2 cells with novel delivery agents: evidence for P-glycoprotein involvement

被引:21
作者
Wu, SJ [1 ]
Robinson, JR [1 ]
机构
[1] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA
关键词
P-glycoprotein; human growth hormone; oral drug delivery; non-covalent carriers; Caco-2; cells;
D O I
10.1016/S0168-3659(99)00035-8
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Emisphere Technologies, Inc. has synthesized a series of small molecules which have been shown to improve protein absorption through mucosal tissue. This enhancement is specific between protein and a particular delivery agent. Despite the specificity of interaction, the mechanism of enhanced tissue penetration is still unclear. The purpose of this work is to understand the enhancement mechanism(s) of these delivery agents by using Caco-2 cells as a model membrane. It was found that the bidirectional transepithelial fluxes of human growth hormone (hGH) in the presence of these delivery agents across human intestinal epithelial Caco-2 cell line showed marked asymmetry. Average permeability coefficient values obtained in the apical (AP) to basolateral (BL) direction were lower than those of the reverse (BL to AP) direction. On the other hand, the fluxes for human growth hormone alone were symmetric. When P-glycoprotein inhibitors were included in the transport medium, the permeability coefficient values of BL to AP direction were significantly decreased while the transport was increased in the reverse direction in the presence of delivery agents. P-glycoprotein inhibitors had no effect on the transport of human growth hormone alone. This study shows that human growth hormone alone can be transported across Caco-2 cells in very limited quantities by passive diffusion, but in the presence of delivery agents, human growth hormone can be effluxed in a P-glycoprotein-mediated fashion. This also indirectly shows that the human growth hormone has become more lipophilic in the presence of delivery agents. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 21 条
[1]
[Anonymous], 1991, PEPT PROTEIN DRUG DE
[2]
Heparin absorption across the intestine:: Effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers [J].
Brayden, D ;
Creed, E ;
O'Connell, A ;
Leipold, H ;
Agarwal, R ;
Leone-Bay, A .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1772-1779
[3]
Folding proteins into membranes [J].
Deber, CM ;
Goto, NK .
NATURE STRUCTURAL BIOLOGY, 1996, 3 (10) :815-818
[4]
PRECIPITINS TO DIETARY PROTEINS IN SERUM AND UPPER INTESTINAL SECRETIONS OF CELIAC CHILDREN [J].
FERGUSON, A ;
CARSWELL, F .
BMJ-BRITISH MEDICAL JOURNAL, 1972, 1 (5792) :75-+
[5]
GASTROINTESTINAL ABSORPTION OF INTACT PROTEINS [J].
GARDNER, MLG .
ANNUAL REVIEW OF NUTRITION, 1988, 8 :329-350
[6]
HUNTER J, 1993, J BIOL CHEM, V268, P14991
[7]
DRUG ABSORPTION LIMITED BY P-GLYCOPROTEIN-MEDIATED SECRETORY DRUG TRANSPORT IN HUMAN INTESTINAL EPITHELIAL CACO-2 CELL-LAYERS [J].
HUNTER, J ;
HIRST, BH ;
SIMMONS, NL .
PHARMACEUTICAL RESEARCH, 1993, 10 (05) :743-749
[8]
Lee V. H. L., 1991, PEPTIDE PROTEIN DRUG, P303
[9]
Lee VH, 1991, PEPTIDE PROTEIN DRUG, P691
[10]
N-ACYLATED ALPHA-AMINO-ACIDS AS NOVEL ORAL DELIVERY AGENTS FOR PROTEINS [J].
LEONEBAY, A ;
SANTIAGO, N ;
ACHAN, D ;
CHAUDHARY, K ;
DEMORIN, F ;
FALZARANO, L ;
HAAS, S ;
KALBAG, S ;
KAPLAN, D ;
LEIPOLD, H ;
LERCARA, C ;
OTOOLE, D ;
RIVERA, T ;
ROSADO, C ;
SARUBBI, D ;
VUOCOLO, E ;
WANG, NF ;
MILSTEIN, S ;
BAUGHMAN, RA .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (21) :4263-4269